A pilot study to compare the response of psoriasis to narrow-band UVB phototherapy in the morning and afternoon (Psoriasis and the Circadian Timing System [Version 1])

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 20 人开始时间: 2020年4月23日最近更新: 2020年5月4日

适应症

试验速览

暂无简介。

•1. Able to control their psoriasis or already controlled by topical therapy
•2. Pregnant
•3. Significant sun exposure, sun-bed use or previous NbUVB within the last month or be planning significant sun exposure or sun-bed use in the next month
•4. Previously taken, in the last three months any of the following: methotrexate, azathioprine, ciclosporin, biological therapy or systemic steroids for treatment of psoriasis
•5. Previously taken, in the last month, any oral photosensitising medications, including: thiazide diuretics, antibiotics such as tetracyclines and quinolones, non-steroidal anti-inflammatory drugs, phenothiazines, retinoids, sulphonylureas, quinine and St John’s Wort
•6. Also suffer from diseases where phototherapeutic treatment is contraindicated: xeroderma pigmentosum, lupus erythematosus
•7. Work night-shifts
•8. Diagnosed circadian rhythm disorder

发起方

ewcastle upon Tyne Hospitals NHS Foundation Trust